AZD5597
AZD5597 is an inhibitor of CDK with IC50 values of both 2 nM for CDK1 and CDK2. AZD5597 can inhibit the proliferation of tumor cells and has anti-tumor activity[1].
Product Specifications
CAS Number
924641-59-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/azd5597.html
Purity
98.09
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(N1C(C2=NC(NC3=CC=C(C=C3)C(N4C[C@H](CC4)NC)=O)=NC=C2F)=CN=C1C)C
Molecular Formula
C23H28FN7O
Molecular Weight
437.51
Precautions
H302, H315, H319, H335
References & Citations
[1]Jones CD, et al.The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing. Bioorg Med Chem Lett. 2008 Dec 15;18 (24) :6369-73.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK1; CDK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2680-01L-ML405 100 µL
BRAF (T400) (Serine/Threonine-protein Kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf Murine Sarcoma Viral Oncogene Homolog B1, BRAF1, RAFB1) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
CSB-CF866221HU(A4)-01 20 µg
Recombinant Human Solute carrier family 23 member 2 (SLC23A2)
Sign In for Pricing
View Details CSB-CF866221HU(A4)-02 100 µg
Recombinant Human Solute carrier family 23 member 2 (SLC23A2)
Sign In for Pricing
View Details